MedPath

Feasiblity of Self-Obtained VAginal Sample for Detection of HPV DNA

Not Applicable
Completed
Conditions
Diseases of The genitoruinary system
Registration Number
KCT0004283
Lead Sponsor
Korea Institute of Radiological & Medical Sciences
Brief Summary

SOVAS obtained by innovative self-sampler, G+Kit®, is feasible, reliable, and comparable to CS to test HPV DNA. Most women feel that the device is acceptable, safe, and comfort and willing to recommend to others.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
151
Inclusion Criteria

•20~65 year aged women with previous sexuall contact and history of HPV positive or abnormal cytology of ASCUS(Atypical squamous cells of undetermined significance) or more

Exclusion Criteria

•Woman without sexuall contact
•Woman with mentruation and any disease which limits the sampling
•Woman who cannot read and understand the guideline
•When the physician determined that she is not able to perfome the study

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differnce of HPV positivity between the vaginal and cevical samples
Secondary Outcome Measures
NameTimeMethod
Feasibility of self sampling
© Copyright 2025. All Rights Reserved by MedPath